API 5000 LC/MS/MS System Package
API 5000 LC/MS/MS 系统套件
基本信息
- 批准号:7219842
- 负责人:
- 金额:$ 42.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-04-01 至 2008-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAntineoplastic AgentsAreaAtmospheric PressureBiologicalBiological MarkersBiomedical EngineeringChemicalsCitiesCommunitiesDNADevicesDrug DesignEnvironmental HealthFacultyFosteringFoxesFundingGoalsHumanInfectious AgentInflammationLipidsLiverMeasuresMechanical StressMethodsProteinsProteomicsPublic HealthRangeResearchResearch Project GrantsScientistSiteSpecificityStressSystemTissuesUnited States National Institutes of Healthbasebench to bedsidedrug metabolismhuman diseasehuman tissueion sourceionizationmass spectrometermicrobial alkaline proteinase inhibitorresponsesystems research
项目摘要
DESCRIPTION (provided by applicant): We are requesting funds for the purchase a new API 5000 tandem quadrupole LC- MS/MS system, with turboionspray and atmospheric-pressure chemical ionization ion sources, manufactured by Applied Biosystems of Foster City, CA. The device will be used by the eight participating faculty, as well as other scientists in the MIT community, to quantify and characterize biological and synthetic molecules in studies affecting at least eighteen NIH-funded research projects. Our current single triple quadrupole mass spectrometer (API 3000) in the Center for Environmental Health Sciences (CEHS) is becoming overwhelmed by sharply increasing demand for LC-MS/MS analyses requiring greater sensitivity, mainly in the area of biomarker quantification. The co-applicants all have demonstrated needs for the API 5000 system for research projects funded by the NIH: Peter Dedon, John Essigmann, James Fox, Alan Grodzinsky, Leona Samson, David Schauer, Steven Tannenbaum, and John Wishnok. The projects that would benefit from the API 5000 range widely from proteomic analyses of cellular responses to infectious agents and mechanical stresses; anticancer drug design; drug metabolism in bioengineered liver tissue; to DNA, RNA, protein and lipid biomarkers of oxidative and nitrosative stress arising at sites of inflammation in humans. In all cases, the goal is to take advantage of the sensitivity and chemical specificity of the API 5000 triple quadrupole mass spectrometer system to rigorously quantify synthetic and biological molecules at the relatively low levels that occur in diseased and healthy human tissues, with sensitivities in the range of attomoles to femtomoles. No other system meets these demands. The public health relevance of the studies that would be supported by the API 5000 lies in their goals to develop sensitive methods to quantify molecules involved in both the therapy and the pathophysiological basis for human diseases. Sensitive measuring devices such as the API 5000 are crucial to the objective of moving NIH-sponsored research into humans - from bench to bedside.
描述(由申请人提供):我们正在申请资金购买一个新的API 5000串联四极杆LC- MS/MS系统,具有涡轮喷雾和大气压化学电离离子源,由加利福尼亚州福斯特市的应用生物系统公司制造。该设备将由8名参与的教师以及麻省理工学院社区的其他科学家使用,在影响至少18个nih资助的研究项目的研究中量化和表征生物和合成分子。我们目前在环境健康科学中心(CEHS)的单三重四极杆质谱仪(API 3000)正变得不堪重负,因为对LC-MS/MS分析的需求急剧增加,需要更高的灵敏度,主要是在生物标志物定量领域。共同申请人都证明了由NIH资助的研究项目对API 5000系统的需求:Peter Dedon, John Essigmann, James Fox, Alan Grodzinsky, Leona Samson, David Schauer, Steven Tannenbaum和John Wishnok。受益于API 5000的项目范围广泛,包括细胞对感染因子和机械应力反应的蛋白质组学分析;抗癌药物设计;生物工程肝组织药物代谢研究到人类炎症部位产生的氧化应激和亚硝化应激的DNA、RNA、蛋白质和脂质生物标志物。在所有情况下,目标是利用API 5000三重四极杆质谱仪系统的灵敏度和化学特异性,严格量化在患病和健康人体组织中相对较低水平的合成和生物分子,灵敏度在原子摩尔到飞摩尔范围内。没有其他系统能满足这些要求。API 5000支持的研究与公共卫生的相关性在于它们的目标是开发敏感的方法来量化涉及人类疾病治疗和病理生理基础的分子。灵敏的测量设备,如API 5000,对于将nih资助的研究从实验室转移到临床至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter C Dedon其他文献
The Spectrum of 8-oxoguanine Oxidation Products is both Sequence and Oxidant Dependent
- DOI:
10.1016/j.freeradbiomed.2010.10.477 - 发表时间:
2010-01-01 - 期刊:
- 影响因子:
- 作者:
Kok Seong Lim;Liang Cui;Koli Taghizadeh;John S Wishnok;Vladimir Shafirovich;Nicholas E Geacintov;Steven R Tannenbaum;Peter C Dedon - 通讯作者:
Peter C Dedon
Peter C Dedon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter C Dedon', 18)}}的其他基金
13th International Workshop on Radiation Damage to DNA
第13届DNA辐射损伤国际研讨会
- 批准号:
8720445 - 财政年份:2014
- 资助金额:
$ 42.43万 - 项目类别:
Sulfur DNA modifications in gut microbes confer resistance to oxidative stress
肠道微生物中的硫 DNA 修饰赋予其对氧化应激的抵抗力
- 批准号:
8751068 - 财政年份:2014
- 资助金额:
$ 42.43万 - 项目类别:
Sulfur DNA modifications in gut microbes confer resistance to oxidative stress
肠道微生物中的硫 DNA 修饰赋予其对氧化应激的抵抗力
- 批准号:
8898718 - 财政年份:2014
- 资助金额:
$ 42.43万 - 项目类别:
Quantitative analysis of damage to the nucleotide pool
核苷酸库损伤的定量分析
- 批准号:
8638724 - 财政年份:2013
- 资助金额:
$ 42.43万 - 项目类别:
DNA and protein reactions of NO', ONOO-, and reactive species produced by phagocy
NO、ONOO- 和吞噬产生的反应性物质的 DNA 和蛋白质反应
- 批准号:
7514461 - 财政年份:2009
- 资助金额:
$ 42.43万 - 项目类别:
Chemistry and Biology of Deoxyribose Oxidation in DNA
DNA 脱氧核糖氧化的化学和生物学
- 批准号:
7911253 - 财政年份:2009
- 资助金额:
$ 42.43万 - 项目类别:
Complex modifications of tRNA: regulatory roles and crosstalk with DNA metabolism
tRNA 的复杂修饰:调节作用以及与 DNA 代谢的串扰
- 批准号:
9134775 - 财政年份:2006
- 资助金额:
$ 42.43万 - 项目类别:
Complex modifications of tRNA: regulatory roles and crosstalk with DNA metabolism
tRNA 的复杂修饰:调节作用以及与 DNA 代谢的串扰
- 批准号:
8884789 - 财政年份:2006
- 资助金额:
$ 42.43万 - 项目类别:
相似海外基金
Delays in Acquisition of Oral Antineoplastic Agents
口服抗肿瘤药物的获取延迟
- 批准号:
9975367 - 财政年份:2020
- 资助金额:
$ 42.43万 - 项目类别:
Eliminate the difficulty of venous puncture in patients receiving antineoplastic agents - Development of a new strategy for the prevention of induration-
消除接受抗肿瘤药物的患者静脉穿刺的困难 - 制定预防硬结的新策略 -
- 批准号:
16K11932 - 财政年份:2016
- 资助金额:
$ 42.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of the antineoplastic agents inhibiting DNA replication and their applications to cancer patient treatmen
抗肿瘤药物抑制DNA复制的分子机制及其在癌症患者治疗中的应用
- 批准号:
19591274 - 财政年份:2007
- 资助金额:
$ 42.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
PNET EXPERIMENTAL THERAPEUTICS--ANTINEOPLASTIC AGENTS AND TREATMENT DELIVERY
PNET 实验治疗——抗肿瘤药物和治疗实施
- 批准号:
6346309 - 财政年份:2000
- 资助金额:
$ 42.43万 - 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
- 批准号:
2885074 - 财政年份:1999
- 资助金额:
$ 42.43万 - 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
- 批准号:
6174221 - 财政年份:1999
- 资助金额:
$ 42.43万 - 项目类别:














{{item.name}}会员




